A 12-week treatment with the investigational therapy omaveloxolone improved neurological function, and was safe and well-tolerated by Friedreich's ... read more
Omaveloxolone Safe, Improves Neurological Function in FA Patients, Phase 2 Trial Shows
Omaveloxolone Safe, Improves Neurological Function in FA Patients, Phase 2 Trial Shows